Canna-Global Acquisition (NASDAQ:CNGL – Get Free Report) and Streamline Health Solutions (NASDAQ:STRM – Get Free Report) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation and institutional ownership.
Profitability
This table compares Canna-Global Acquisition and Streamline Health Solutions’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Canna-Global Acquisition | N/A | N/A | N/A |
Streamline Health Solutions | -92.72% | -44.85% | -19.68% |
Insider & Institutional Ownership
19.6% of Canna-Global Acquisition shares are held by institutional investors. Comparatively, 31.7% of Streamline Health Solutions shares are held by institutional investors. 72.1% of Canna-Global Acquisition shares are held by company insiders. Comparatively, 30.6% of Streamline Health Solutions shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Canna-Global Acquisition | 0 | 0 | 0 | 0 | 0.00 |
Streamline Health Solutions | 0 | 0 | 0 | 1 | 4.00 |
Earnings & Valuation
This table compares Canna-Global Acquisition and Streamline Health Solutions”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Canna-Global Acquisition | N/A | N/A | N/A | N/A | N/A |
Streamline Health Solutions | $20.30 million | 0.61 | -$18.70 million | ($4.95) | -0.59 |
Canna-Global Acquisition has higher earnings, but lower revenue than Streamline Health Solutions.
Risk & Volatility
Canna-Global Acquisition has a beta of -0.01, suggesting that its share price is 101% less volatile than the S&P 500. Comparatively, Streamline Health Solutions has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500.
Summary
Streamline Health Solutions beats Canna-Global Acquisition on 5 of the 9 factors compared between the two stocks.
About Canna-Global Acquisition
Canna-Global Acquisition Corp. does not have significant operations. The company intends to acquire and engage in a share exchange, share reconstruction, and amalgamation with one or more businesses or entities. It intends to focus its search of target business in the cannabis industry. The company was incorporated in 2021 and is based in Marina Del Rey, California.
About Streamline Health Solutions
Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management. It also provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.
Receive News & Ratings for Canna-Global Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canna-Global Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.